Syndax Pharmaceuticals Inc reports financial results in SEC 8-K

Syndax Pharmaceuticals Inc filed an 8-K covering results of operations or financial condition and director or executive-officer changes. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.